SCUTERI, ALESSANDRA
 Distribuzione geografica
Continente #
NA - Nord America 792
EU - Europa 454
AS - Asia 211
AF - Africa 58
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
SA - Sud America 1
Totale 1518
Nazione #
US - Stati Uniti d'America 790
GB - Regno Unito 185
SE - Svezia 120
CN - Cina 86
VN - Vietnam 81
TG - Togo 43
IT - Italia 35
IN - India 34
DE - Germania 33
RU - Federazione Russa 20
FR - Francia 19
EE - Estonia 15
ZA - Sudafrica 15
UA - Ucraina 8
GR - Grecia 6
BE - Belgio 5
IR - Iran 5
CH - Svizzera 3
CA - Canada 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AU - Australia 1
BG - Bulgaria 1
CL - Cile 1
HK - Hong Kong 1
JP - Giappone 1
KR - Corea 1
LB - Libano 1
MD - Moldavia 1
PL - Polonia 1
RO - Romania 1
SI - Slovenia 1
TW - Taiwan 1
Totale 1518
Città #
Southend 175
Fairfield 126
Ann Arbor 74
Ashburn 63
Dong Ket 61
Seattle 57
Wilmington 57
Woodbridge 56
Houston 52
Chandler 48
Cambridge 47
Lomé 43
Princeton 41
Nanjing 23
Westminster 18
Padova 15
San Diego 11
Dearborn 10
Jinan 10
Saint Petersburg 10
Berlin 9
Bologna 8
Changsha 8
Des Moines 7
Dolo 7
Jiaxing 7
Medford 7
Shenyang 7
Redmond 6
Brussels 5
Buffalo 4
Falls Church 4
Hebei 4
Nanchang 4
Beijing 3
Kunming 3
Norwalk 3
Ardabil 2
Lanzhou 2
Milan 2
Monmouth Junction 2
Ningbo 2
Plauen 2
Aachen 1
Athens 1
Central District 1
Chengdu 1
Chisinau 1
Coominya 1
Costa Mesa 1
Frankfurt am Main 1
Grafing 1
Haikou 1
Hangzhou 1
Hanover 1
Jacksonville 1
Las Vegas 1
Leawood 1
Ljubljana 1
Montespertoli 1
Nanning 1
North York 1
Redwood City 1
Sacramento 1
San Francisco 1
Shaoxing 1
Silverton 1
Sofia 1
Taipei 1
Taizhou 1
Tianjin 1
Tokyo 1
Toronto 1
Ulan-ude 1
Zanjan 1
Zhengzhou 1
Totale 1138
Nome #
Add-on peginterferon alfa-2a to nucleos(t)ide analogue therapy for Caucasian patients with hepatitis B ‘e’ antigen-negative chronic hepatitis B genotype D 112
null 107
Liver Stiffness measurments using Fibroscan after three months of IFN-based antiviral therapy is unlikely to predict viral response in cirrhotic patients. 107
Hepatitis C Virus-related chronic liver disease in elderly patients: an Italian cross-sectional study. 100
A Case of Acute Liver Failure during Ritonavir-Boosted Paritaprevir, Ombitasvir and Dasabuvir Therapy in a Patient with HCV Genotype 1b Cirrhosis 98
null 92
Treatment with direct acting antiviral agents-based regimen in HCV patients with advanced liver disease: Analysis of an Italian multicenter observational study 91
Hepatitis B virus reactivation among hepatitis C patients treated with direct-acting antiviral therapies in routine clinical practice 91
Direct acting antivirals for the treatment of elderly patients with HCV advanced disease in the real life practice 88
Secondary prophylaxis of hepatocellular carcinoma: the comparison of direct-acting antivirals with pegylated interferon and untreated cohort 87
In vitro effect of thymosin-alpha1 and interferon-alpha on Th1 and Th2 cytokine synthesis in patients with eAg-negative chronic hepatitis B. 84
Hepatocellular carcinoma appearance in patients with hepatitis C virus-related chronic liver disease 90 and 70 months after sustained virological response to interferon and ribavirin 83
Antibodies against pegylated interferon-alpha affect response to treatment in patients with chronic hepatitis C. 83
Two years Mycophenolate Mofetil plus low dose calcineurin inhibitor for renal dysfunction after liver transplantation. 77
Immunological modifications during treatment with thymosin alpha 1 plus antiviral therapy in chronic hepatitis C. 65
The increase of Ribavirin dose improves sustained virological response in HCV-Genotype 1 patients with a partial response to PEG-Interferon and Ribavirin. 63
Development of psychiatric symptoms during antiviral therapy for chronic hepatitis C: a retrospective study on 590 subjects. 37
Uno studio retrospettivo su 590 soggetti: sintomi psichiatrici durante la terapia antivirale per l’epatite cronica C. 31
Transjugular Intrahepatic Portosystemic Shunt does not affect the efficacy and safety of direct-acting antivirals in patients with advanced cirrhosis: A real-life, case-control study 29
Psychiatric symptoms during antiviral therapy for chronic hepatitis C: a retrospective study on 590 subjects 26
Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals 13
Worsening of Serum Lipid Profile after Direct Acting Antiviral Treatment 12
Totale 1576
Categoria #
all - tutte 2120
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2120


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/201831 0000 00 02 00290
2018/201995 11703 113 66 3161514
2019/2020538 6913227 5763 7569 7829947
2020/2021250 443042 13 820 1918992
2021/2022457 36262832 3724 621 126011362
2022/2023190 52103323 00 00 0000
Totale 1576